Ocaratuzumab

An Fc-engineered monoclonal antibody directed against human CD20 with potential antineoplastic activity. Ocaratuzumab specifically binds to CD20 antigen (B1), preventing mitogen-induced B-cell proliferation; inhibiting B-cell differentiation; and promoting antibody-dependent cell-mediated cytotoxicity (ADCC) and apoptosis of B cells expressing CD20. The Fc portion of this monoclonal antibody has been engineered to possess a higher binding affinity for variant Fc receptors on T helper cells, resulting in an augmentation of the anti-tumor immune response. Because of Fc engineering, this agent may be significantly more potent than rituximab in inducing B cell-directed ADCC. CD20 is a non-glycosylated cell surface phosphoprotein that is exclusively expressed on B cells during most stages of B cell development. (NCI Thesaurus)

YOU MAY ALSO LIKE

Obturator Vein

A vein that drains the hip joint, obturator, and adductor muscles of the thigh into the internal iliac vein.

Obturator Nerve

A nerve that arises from the second, third, and fourth lumbar nerves and enters the thigh through the obturator canal. It is…

Obturator Lymph Node

A pelvic lymph node located along the obturator artery.

Obturator Foramen

An opening in the hip bone formed by the public bone and the ischium and closed by the obturator membrane.

Obturator Device Component

A plug-like device used to close an opening in a body structure or a removable plug used during the insertion of a…

Obturator Artery

An artery arising from the anterior or posterior trunk of the internal iliac artery that supplies the ilium and pubic bones as…